News
11-11-2016, 05:00 AM
Using synthetic DNA sequences as the tiniest of barcodes, Technion researchers have developed a new diagnostic technology for determining the suitability of specific anticancer drugs to a specific patient - before treatment even begins.
More... (http://www.news-medical.net/news/20161111/Technion-researchers-develop-new-diagnostic-technology-forc2a0improving-personalized-cancer-treatment.aspx)
More... (http://www.news-medical.net/news/20161111/Technion-researchers-develop-new-diagnostic-technology-forc2a0improving-personalized-cancer-treatment.aspx)